Patent ID: 7718599

Claim:
A pharmaceutical composition for parenteral administration, comprising: (a) a pharmaceutically effective amount of the peptidic LHRH antagonist salt cetrorelix acetate, in a concentration of 2.5 mg/ml total solution; (b) a pharmaceutically acceptable acid and % in total solution thereof, selected from the group consisting of gluconic acid of 0.00710%, 0.071, or 0.71%, or glucaric acid or galacturonic acid of 2.5%, wherein the pharmaceutically acceptable acid is present as free acid and is in an amount capable of imparting a pH of 2.5, 2.6, 3.1, 3.7, or 4.5 to the composition and suppressing aggregation of cetrorelix acetate; and (c) a carrier, wherein the carrier is water or an aqueous solvent mixture.